Mercoledì, 19 Settembre 2018

Controversial stem-cell treatment resumes for toddler


(ANSA) - Venice, August 24 - Controversial stem-cell
treatment on a toddler from Venice, believed necessary to save
her life, resumed Friday in northern Italy.
Celeste Carrer, the two-year-old at the centre of a
controversy involving the treatment, arrived at the Brescia
hospital Friday morning after a judge ordered the immediate
resumption of her treatment.
Infusions of adult stem cells taken from the child's mother
resume under the care of pediatrician Dr. Marino Andolina.
Over the past year and a half, Celeste has received
stem-cell transplants from her mother's bone marrow to treat her
spinal muscular atrophy, which causes the toddler's muscles to
waste away.
Celeste was reportedly able to move her neck, arms, and
legs following an earlier treatment.
However, her treatments were halted in May when a Turin
prosecutor launched an investigation into the Stamina
Foundation, the stem-cell research group that carried out her
treatments at the Brescia hospital.
Police raided the hospital in May, blocking treatment for
numerous other patients, according to staff.
The case returns to the courtroom next Tuesday, when judge
Margherita Bortolaso, who had allowed this week's treatment to
resume, will make a final ruling.
Stem-cell treatment, which is legal in Italy in
life-threatening instances, is contentious since it sometimes
involves the destruction of a human embryo.
Italy banned the use of embryos in stem cell research in
2004, and in 2007 Italian researchers obtained adult stem cells
they said were just as good as embryonic ones.

© Riproduzione riservata

* Campi obbligatori

Immagine non superiore a 5Mb (Formati permessi: JPG, JPEG, PNG)
Video non superiore a 10Mb (Formati permessi: MP4, MOV, M4V)


Accedi con il tuo account Facebook

Login con

Login con Facebook